Get Real Time Here
| Open1.260 | Close1.650 |
| Vol / Avg.3.094M / 246.588K | Mkt Cap41.927M |
| Day Range1.250 - 1.700 | 52 Wk Range1.235 - 10.200 |
Leap Therapeutics Stock (NASDAQ:LPTX), Quotes and News Summary
Leap Therapeutics Stock (NASDAQ: LPTX) stock price, news, charts, stock research, profile.
| Open1.260 | Close1.650 |
| Vol / Avg.3.094M / 246.588K | Mkt Cap41.927M |
| Day Range1.250 - 1.700 | 52 Wk Range1.235 - 10.200 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.910 | -0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Baird | Joel Beatty | Maintains | OutperformOutperform | Lowers | 30.00 | 20.00 |
| 2023-08-15 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | BuyBuy | Raises | 2.50 | 7.00 |
| 2023-07-13 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Raises | 17.00 | 18.50 |
| 2023-06-23 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Lowers | 20.00 | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LPTX | Leap Therapeutics | 26.15% | 41.9M |
| CRIS | Curis | -1.35% | 30.2M |
| COEP | Coeptis Therapeutics | 0% | 33.5M |
| PHXM | PHAXIAM Therapeutics | -6.4% | 28.9M |
| ALGS | Aligos Therapeutics | -4.01% | 33.4M |
How do I buy Leap Therapeutics (LPTX) stock?
You can purchase shares of Leap Therapeutics (NASDAQ: LPTX) through any online brokerage.
Who are Leap Therapeutics's (LPTX) competitors?
Other companies in Leap Therapeutics’s space includes: Curis (NASDAQ:CRIS), Coeptis Therapeutics (NASDAQ:COEP), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS) and NuCana (NASDAQ:NCNA).
What is the target price for Leap Therapeutics (LPTX) stock?
The latest price target for Leap Therapeutics (NASDAQ: LPTX) was reported by Baird on Tuesday, August 15, 2023. The analyst firm set a price target for 20.00 expecting LPTX to rise to within 12 months (a possible 1119.51% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Leap Therapeutics (LPTX)?
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $1.64 last updated October 3, 2023 at 11:40 PM UTC.
Does Leap Therapeutics (LPTX) pay a dividend?
There is no dividend information for Leap Therapeutics.
When is Leap Therapeutics (NASDAQ:LPTX) reporting earnings?
Leap Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Leap Therapeutics (LPTX) going to split?
There is no upcoming split for Leap Therapeutics.
What sector and industry does Leap Therapeutics (LPTX) operate in?
Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Leap Therapeutics Stock (NASDAQ:LPTX), Quotes and News Summary
Leap Therapeutics Stock (NASDAQ: LPTX) stock price, news, charts, stock research, profile.
| Open1.260 | Close1.650 |
| Vol / Avg.3.094M / 246.588K | Mkt Cap41.927M |
| Day Range1.250 - 1.700 | 52 Wk Range1.235 - 10.200 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.910 | -0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Baird | Joel Beatty | Maintains | OutperformOutperform | Lowers | 30.00 | 20.00 |
| 2023-08-15 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | BuyBuy | Raises | 2.50 | 7.00 |
| 2023-07-13 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Raises | 17.00 | 18.50 |
| 2023-06-23 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Lowers | 20.00 | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LPTX | Leap Therapeutics | 26.15% | 41.9M |
| CRIS | Curis | -1.35% | 30.2M |
| COEP | Coeptis Therapeutics | 0% | 33.5M |
| PHXM | PHAXIAM Therapeutics | -6.4% | 28.9M |
| ALGS | Aligos Therapeutics | -4.01% | 33.4M |
How do I buy Leap Therapeutics (LPTX) stock?
You can purchase shares of Leap Therapeutics (NASDAQ: LPTX) through any online brokerage.
Who are Leap Therapeutics's (LPTX) competitors?
Other companies in Leap Therapeutics’s space includes: Curis (NASDAQ:CRIS), Coeptis Therapeutics (NASDAQ:COEP), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS) and NuCana (NASDAQ:NCNA).
What is the target price for Leap Therapeutics (LPTX) stock?
The latest price target for Leap Therapeutics (NASDAQ: LPTX) was reported by Baird on Tuesday, August 15, 2023. The analyst firm set a price target for 20.00 expecting LPTX to rise to within 12 months (a possible 1119.51% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Leap Therapeutics (LPTX)?
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $1.64 last updated October 3, 2023 at 11:40 PM UTC.
Does Leap Therapeutics (LPTX) pay a dividend?
There is no dividend information for Leap Therapeutics.
When is Leap Therapeutics (NASDAQ:LPTX) reporting earnings?
Leap Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Leap Therapeutics (LPTX) going to split?
There is no upcoming split for Leap Therapeutics.
What sector and industry does Leap Therapeutics (LPTX) operate in?
Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Leap Therapeutics Stock (NASDAQ:LPTX), Quotes and News Summary
Leap Therapeutics Stock (NASDAQ: LPTX) stock price, news, charts, stock research, profile.
| Open1.260 | Close1.650 |
| Vol / Avg.3.094M / 246.588K | Mkt Cap41.927M |
| Day Range1.250 - 1.700 | 52 Wk Range1.235 - 10.200 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.910 | -0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Baird | Joel Beatty | Maintains | OutperformOutperform | Lowers | 30.00 | 20.00 |
| 2023-08-15 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | BuyBuy | Raises | 2.50 | 7.00 |
| 2023-07-13 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Raises | 17.00 | 18.50 |
| 2023-06-23 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Lowers | 20.00 | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LPTX | Leap Therapeutics | 26.15% | 41.9M |
| CRIS | Curis | -1.35% | 30.2M |
| COEP | Coeptis Therapeutics | 0% | 33.5M |
| PHXM | PHAXIAM Therapeutics | -6.4% | 28.9M |
| ALGS | Aligos Therapeutics | -4.01% | 33.4M |
How do I buy Leap Therapeutics (LPTX) stock?
You can purchase shares of Leap Therapeutics (NASDAQ: LPTX) through any online brokerage.
Who are Leap Therapeutics's (LPTX) competitors?
Other companies in Leap Therapeutics’s space includes: Curis (NASDAQ:CRIS), Coeptis Therapeutics (NASDAQ:COEP), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS) and NuCana (NASDAQ:NCNA).
What is the target price for Leap Therapeutics (LPTX) stock?
The latest price target for Leap Therapeutics (NASDAQ: LPTX) was reported by Baird on Tuesday, August 15, 2023. The analyst firm set a price target for 20.00 expecting LPTX to rise to within 12 months (a possible 1119.51% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Leap Therapeutics (LPTX)?
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $1.64 last updated October 3, 2023 at 11:40 PM UTC.
Does Leap Therapeutics (LPTX) pay a dividend?
There is no dividend information for Leap Therapeutics.
When is Leap Therapeutics (NASDAQ:LPTX) reporting earnings?
Leap Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Leap Therapeutics (LPTX) going to split?
There is no upcoming split for Leap Therapeutics.
What sector and industry does Leap Therapeutics (LPTX) operate in?
Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Leap Therapeutics Stock (NASDAQ:LPTX), Quotes and News Summary
Leap Therapeutics Stock (NASDAQ: LPTX) stock price, news, charts, stock research, profile.
| Open1.260 | Close1.650 |
| Vol / Avg.3.094M / 246.588K | Mkt Cap41.927M |
| Day Range1.250 - 1.700 | 52 Wk Range1.235 - 10.200 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.910 | -0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Baird | Joel Beatty | Maintains | OutperformOutperform | Lowers | 30.00 | 20.00 |
| 2023-08-15 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | BuyBuy | Raises | 2.50 | 7.00 |
| 2023-07-13 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Raises | 17.00 | 18.50 |
| 2023-06-23 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Lowers | 20.00 | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LPTX | Leap Therapeutics | 26.15% | 41.9M |
| CRIS | Curis | -1.35% | 30.2M |
| COEP | Coeptis Therapeutics | 0% | 33.5M |
| PHXM | PHAXIAM Therapeutics | -6.4% | 28.9M |
| ALGS | Aligos Therapeutics | -4.01% | 33.4M |
How do I buy Leap Therapeutics (LPTX) stock?
You can purchase shares of Leap Therapeutics (NASDAQ: LPTX) through any online brokerage.
Who are Leap Therapeutics's (LPTX) competitors?
Other companies in Leap Therapeutics’s space includes: Curis (NASDAQ:CRIS), Coeptis Therapeutics (NASDAQ:COEP), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS) and NuCana (NASDAQ:NCNA).
What is the target price for Leap Therapeutics (LPTX) stock?
The latest price target for Leap Therapeutics (NASDAQ: LPTX) was reported by Baird on Tuesday, August 15, 2023. The analyst firm set a price target for 20.00 expecting LPTX to rise to within 12 months (a possible 1119.51% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Leap Therapeutics (LPTX)?
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $1.64 last updated October 3, 2023 at 11:40 PM UTC.
Does Leap Therapeutics (LPTX) pay a dividend?
There is no dividend information for Leap Therapeutics.
When is Leap Therapeutics (NASDAQ:LPTX) reporting earnings?
Leap Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Leap Therapeutics (LPTX) going to split?
There is no upcoming split for Leap Therapeutics.
What sector and industry does Leap Therapeutics (LPTX) operate in?
Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Leap Therapeutics Stock (NASDAQ:LPTX), Quotes and News Summary
Leap Therapeutics Stock (NASDAQ: LPTX) stock price, news, charts, stock research, profile.
| Open1.260 | Close1.650 |
| Vol / Avg.3.094M / 246.588K | Mkt Cap41.927M |
| Day Range1.250 - 1.700 | 52 Wk Range1.235 - 10.200 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.910 | -0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Baird | Joel Beatty | Maintains | OutperformOutperform | Lowers | 30.00 | 20.00 |
| 2023-08-15 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | BuyBuy | Raises | 2.50 | 7.00 |
| 2023-07-13 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Raises | 17.00 | 18.50 |
| 2023-06-23 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Lowers | 20.00 | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LPTX | Leap Therapeutics | 26.15% | 41.9M |
| CRIS | Curis | -1.35% | 30.2M |
| COEP | Coeptis Therapeutics | 0% | 33.5M |
| PHXM | PHAXIAM Therapeutics | -6.4% | 28.9M |
| ALGS | Aligos Therapeutics | -4.01% | 33.4M |
How do I buy Leap Therapeutics (LPTX) stock?
You can purchase shares of Leap Therapeutics (NASDAQ: LPTX) through any online brokerage.
Who are Leap Therapeutics's (LPTX) competitors?
Other companies in Leap Therapeutics’s space includes: Curis (NASDAQ:CRIS), Coeptis Therapeutics (NASDAQ:COEP), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS) and NuCana (NASDAQ:NCNA).
What is the target price for Leap Therapeutics (LPTX) stock?
The latest price target for Leap Therapeutics (NASDAQ: LPTX) was reported by Baird on Tuesday, August 15, 2023. The analyst firm set a price target for 20.00 expecting LPTX to rise to within 12 months (a possible 1119.51% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Leap Therapeutics (LPTX)?
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $1.64 last updated October 3, 2023 at 11:40 PM UTC.
Does Leap Therapeutics (LPTX) pay a dividend?
There is no dividend information for Leap Therapeutics.
When is Leap Therapeutics (NASDAQ:LPTX) reporting earnings?
Leap Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Leap Therapeutics (LPTX) going to split?
There is no upcoming split for Leap Therapeutics.
What sector and industry does Leap Therapeutics (LPTX) operate in?
Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Leap Therapeutics Stock (NASDAQ:LPTX), Quotes and News Summary
Leap Therapeutics Stock (NASDAQ: LPTX) stock price, news, charts, stock research, profile.
| Open1.260 | Close1.650 |
| Vol / Avg.3.094M / 246.588K | Mkt Cap41.927M |
| Day Range1.250 - 1.700 | 52 Wk Range1.235 - 10.200 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.910 | -0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Baird | Joel Beatty | Maintains | OutperformOutperform | Lowers | 30.00 | 20.00 |
| 2023-08-15 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | BuyBuy | Raises | 2.50 | 7.00 |
| 2023-07-13 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Raises | 17.00 | 18.50 |
| 2023-06-23 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Lowers | 20.00 | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LPTX | Leap Therapeutics | 26.15% | 41.9M |
| CRIS | Curis | -1.35% | 30.2M |
| COEP | Coeptis Therapeutics | 0% | 33.5M |
| PHXM | PHAXIAM Therapeutics | -6.4% | 28.9M |
| ALGS | Aligos Therapeutics | -4.01% | 33.4M |
How do I buy Leap Therapeutics (LPTX) stock?
You can purchase shares of Leap Therapeutics (NASDAQ: LPTX) through any online brokerage.
Who are Leap Therapeutics's (LPTX) competitors?
Other companies in Leap Therapeutics’s space includes: Curis (NASDAQ:CRIS), Coeptis Therapeutics (NASDAQ:COEP), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS) and NuCana (NASDAQ:NCNA).
What is the target price for Leap Therapeutics (LPTX) stock?
The latest price target for Leap Therapeutics (NASDAQ: LPTX) was reported by Baird on Tuesday, August 15, 2023. The analyst firm set a price target for 20.00 expecting LPTX to rise to within 12 months (a possible 1119.51% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Leap Therapeutics (LPTX)?
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $1.64 last updated October 3, 2023 at 11:40 PM UTC.
Does Leap Therapeutics (LPTX) pay a dividend?
There is no dividend information for Leap Therapeutics.
When is Leap Therapeutics (NASDAQ:LPTX) reporting earnings?
Leap Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Leap Therapeutics (LPTX) going to split?
There is no upcoming split for Leap Therapeutics.
What sector and industry does Leap Therapeutics (LPTX) operate in?
Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Leap Therapeutics Stock (NASDAQ:LPTX), Quotes and News Summary
Leap Therapeutics Stock (NASDAQ: LPTX) stock price, news, charts, stock research, profile.
| Open1.260 | Close1.650 |
| Vol / Avg.3.094M / 246.588K | Mkt Cap41.927M |
| Day Range1.250 - 1.700 | 52 Wk Range1.235 - 10.200 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.910 | -0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Baird | Joel Beatty | Maintains | OutperformOutperform | Lowers | 30.00 | 20.00 |
| 2023-08-15 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | BuyBuy | Raises | 2.50 | 7.00 |
| 2023-07-13 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Raises | 17.00 | 18.50 |
| 2023-06-23 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Lowers | 20.00 | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LPTX | Leap Therapeutics | 26.15% | 41.9M |
| CRIS | Curis | -1.35% | 30.2M |
| COEP | Coeptis Therapeutics | 0% | 33.5M |
| PHXM | PHAXIAM Therapeutics | -6.4% | 28.9M |
| ALGS | Aligos Therapeutics | -4.01% | 33.4M |
How do I buy Leap Therapeutics (LPTX) stock?
You can purchase shares of Leap Therapeutics (NASDAQ: LPTX) through any online brokerage.
Who are Leap Therapeutics's (LPTX) competitors?
Other companies in Leap Therapeutics’s space includes: Curis (NASDAQ:CRIS), Coeptis Therapeutics (NASDAQ:COEP), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS) and NuCana (NASDAQ:NCNA).
What is the target price for Leap Therapeutics (LPTX) stock?
The latest price target for Leap Therapeutics (NASDAQ: LPTX) was reported by Baird on Tuesday, August 15, 2023. The analyst firm set a price target for 20.00 expecting LPTX to rise to within 12 months (a possible 1119.51% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Leap Therapeutics (LPTX)?
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $1.64 last updated October 3, 2023 at 11:40 PM UTC.
Does Leap Therapeutics (LPTX) pay a dividend?
There is no dividend information for Leap Therapeutics.
When is Leap Therapeutics (NASDAQ:LPTX) reporting earnings?
Leap Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Leap Therapeutics (LPTX) going to split?
There is no upcoming split for Leap Therapeutics.
What sector and industry does Leap Therapeutics (LPTX) operate in?
Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Leap Therapeutics Stock (NASDAQ:LPTX), Quotes and News Summary
Leap Therapeutics Stock (NASDAQ: LPTX) stock price, news, charts, stock research, profile.
| Open1.260 | Close1.650 |
| Vol / Avg.3.094M / 246.588K | Mkt Cap41.927M |
| Day Range1.250 - 1.700 | 52 Wk Range1.235 - 10.200 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.910 | -0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Baird | Joel Beatty | Maintains | OutperformOutperform | Lowers | 30.00 | 20.00 |
| 2023-08-15 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | BuyBuy | Raises | 2.50 | 7.00 |
| 2023-07-13 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Raises | 17.00 | 18.50 |
| 2023-06-23 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Lowers | 20.00 | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LPTX | Leap Therapeutics | 26.15% | 41.9M |
| CRIS | Curis | -1.35% | 30.2M |
| COEP | Coeptis Therapeutics | 0% | 33.5M |
| PHXM | PHAXIAM Therapeutics | -6.4% | 28.9M |
| ALGS | Aligos Therapeutics | -4.01% | 33.4M |
How do I buy Leap Therapeutics (LPTX) stock?
You can purchase shares of Leap Therapeutics (NASDAQ: LPTX) through any online brokerage.
Who are Leap Therapeutics's (LPTX) competitors?
Other companies in Leap Therapeutics’s space includes: Curis (NASDAQ:CRIS), Coeptis Therapeutics (NASDAQ:COEP), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS) and NuCana (NASDAQ:NCNA).
What is the target price for Leap Therapeutics (LPTX) stock?
The latest price target for Leap Therapeutics (NASDAQ: LPTX) was reported by Baird on Tuesday, August 15, 2023. The analyst firm set a price target for 20.00 expecting LPTX to rise to within 12 months (a possible 1119.51% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Leap Therapeutics (LPTX)?
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $1.64 last updated October 3, 2023 at 11:40 PM UTC.
Does Leap Therapeutics (LPTX) pay a dividend?
There is no dividend information for Leap Therapeutics.
When is Leap Therapeutics (NASDAQ:LPTX) reporting earnings?
Leap Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Leap Therapeutics (LPTX) going to split?
There is no upcoming split for Leap Therapeutics.
What sector and industry does Leap Therapeutics (LPTX) operate in?
Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Leap Therapeutics Stock (NASDAQ:LPTX), Quotes and News Summary
Leap Therapeutics Stock (NASDAQ: LPTX) stock price, news, charts, stock research, profile.
| Open1.260 | Close1.650 |
| Vol / Avg.3.094M / 246.588K | Mkt Cap41.927M |
| Day Range1.250 - 1.700 | 52 Wk Range1.235 - 10.200 |
Earnings
see more| Q3 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED) | ||||||
| REV | |||||||
| Q2 2023 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.900 | -0.910 | -0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|---|---|---|---|---|---|---|
| 2023-08-15 | Baird | Joel Beatty | Maintains | OutperformOutperform | Lowers | 30.00 | 20.00 |
| 2023-08-15 | HC Wainwright & Co. | Swayampakula Ramakanth | Maintains | BuyBuy | Raises | 2.50 | 7.00 |
| 2023-07-13 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Raises | 17.00 | 18.50 |
| 2023-06-23 | Raymond James | Steven Seedhouse | Maintains | OutperformOutperform | Lowers | 20.00 | 17.00 |
Related Companies
| Ticker | Company | Chg % | Mkt Cap |
|---|---|---|---|
| LPTX | Leap Therapeutics | 26.15% | 41.9M |
| CRIS | Curis | -1.35% | 30.2M |
| COEP | Coeptis Therapeutics | 0% | 33.5M |
| PHXM | PHAXIAM Therapeutics | -6.4% | 28.9M |
| ALGS | Aligos Therapeutics | -4.01% | 33.4M |
How do I buy Leap Therapeutics (LPTX) stock?
You can purchase shares of Leap Therapeutics (NASDAQ: LPTX) through any online brokerage.
Who are Leap Therapeutics's (LPTX) competitors?
Other companies in Leap Therapeutics’s space includes: Curis (NASDAQ:CRIS), Coeptis Therapeutics (NASDAQ:COEP), PHAXIAM Therapeutics (NASDAQ:PHXM), Aligos Therapeutics (NASDAQ:ALGS) and NuCana (NASDAQ:NCNA).
What is the target price for Leap Therapeutics (LPTX) stock?
The latest price target for Leap Therapeutics (NASDAQ: LPTX) was reported by Baird on Tuesday, August 15, 2023. The analyst firm set a price target for 20.00 expecting LPTX to rise to within 12 months (a possible 1119.51% upside). 12 analyst firms have reported ratings in the last year.
Current Stock Price for Leap Therapeutics (LPTX)?
The stock price for Leap Therapeutics (NASDAQ: LPTX) is $1.64 last updated October 3, 2023 at 11:40 PM UTC.
Does Leap Therapeutics (LPTX) pay a dividend?
There is no dividend information for Leap Therapeutics.
When is Leap Therapeutics (NASDAQ:LPTX) reporting earnings?
Leap Therapeutics’s Q3 earnings are confirmed for Monday, November 13, 2023.
Is Leap Therapeutics (LPTX) going to split?
There is no upcoming split for Leap Therapeutics.
What sector and industry does Leap Therapeutics (LPTX) operate in?
Leap Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.